Reports for APOTEX INC
Company Name APOTEX INC |
||
|---|---|---|
Totals |
||
Shortage reports |
3367 |
|
| Actual shortage: | 219 (7%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 3138 (93%) | |
Discontinuation Reports |
365 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 341 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
144 (4%) |
|
Overdue reports |
68 (28%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-ACEBUTOLOL | 200MG | TABLET | Resolved | 2024-08-22 | 2024-09-06 | 235708 |
| APO-ACEBUTOLOL | 200MG | TABLET | Resolved | 2023-11-17 | 2023-12-15 | 210707 |
| APO-ACEBUTOLOL | 400MG | TABLET | Resolved | 2017-09-04 | 2018-11-09 | 20854 |
| APO-ACEBUTOLOL | 200MG | TABLET | Resolved | 2017-09-04 | 2018-11-09 | 20849 |
| APO-ACEBUTOLOL | 100MG | TABLET | Resolved | 2017-09-04 | 2018-11-09 | 20846 |
| APO-ACEBUTOLOL | 400MG | TABLET | Resolved | 2024-05-31 | 2024-09-06 | 229410 |
| APO-ACEBUTOLOL | 200MG | TABLET | Resolved | 2023-02-23 | 2023-03-16 | 185448 |
| APO-ACETAMINOPHEN | 325MG | TABLET | Resolved | 2024-08-01 | 2024-08-16 | 234283 |
| APO-ACETAMINOPHEN | 325MG | TABLET | Resolved | 2024-10-18 | 2025-01-03 | 240635 |
| APO-ACETAMINOPHEN | 325MG | TABLET | Resolved | 2022-08-09 | 2022-10-20 | 166399 |
| APO-ACETAMINOPHEN | 325MG | TABLET | Resolved | 2022-05-13 | 2022-07-11 | 160601 |
| APO-ACETAMINOPHEN | 325MG | TABLET | Resolved | 2021-09-24 | 2021-09-28 | 146151 |
| APO-ACETAMINOPHEN | 325MG | TABLET | Resolved | 2022-09-23 | 2022-10-21 | 170106 |
| APO-ACETAMINOPHEN CAPLETS | 325MG | TABLET | Resolved | 2024-01-19 | 2024-02-23 | 216656 |
| APO-ACETAMINOPHEN CAPLETS | 325MG | TABLET | Resolved | 2022-05-27 | 2022-07-11 | 161436 |
| APO-ACETAMINOPHEN CAPLETS | 325MG | TABLET | Resolved | 2022-12-05 | 2023-01-06 | 177111 |
| APO-ACETAMINOPHEN CAPLETS | 325MG | TABLET | Resolved | 2022-04-08 | 2022-05-13 | 158336 |
| APO-ACETAMINOPHEN CAPLETS | 325MG | TABLET | Resolved | 2022-10-07 | 2022-10-21 | 171417 |
| APO-ACETAMINOPHEN CAPLETS | 325MG | TABLET | Resolved | 2022-08-26 | 2022-09-23 | 168041 |
| APO-ACETAMINOPHEN CAPLETS 500MG | 500MG | TABLET | Resolved | 2019-09-04 | 2020-01-07 | 92962 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-HYDROMORPHONE CR | 3MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110956 |
| APO-HYDROMORPHONE CR | 6MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110959 |
| APO-HYDROMORPHONE CR | 24MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110968 |
| APO-HYDROMORPHONE CR | 18MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110965 |
| APO-HYDROMORPHONE CR | 12MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110962 |
| APO-HYDROMORPHONE CR | 30MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110971 |
| APO-HYDROXYQUINE | 200MG | TABLET | Discontinued | 2018-09-07 | 2018-10-05 | 60524 |
| APO-IMIQUIMOD | Discontinued | 2019-11-26 | 2019-11-26 | 99672 | ||
| APO-IRBESARTAN | 75MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71231 |
| APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71234 |
| APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60536 |
| APO-IRBESARTAN | 300MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60539 |
| APO-IRBESARTAN | 300MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71237 |
| APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-02-23 | 40757 |
| APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-07-17 | 40760 |
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-02-23 | 2018-07-17 | 40763 | ||
| APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40766 |
| APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40769 |
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-09-07 | 2018-09-15 | 60548 | ||
| APO-LAMIVUDINE | 150MG | TABLET | Discontinued | 2018-09-07 | 2019-07-13 | 60557 |